Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase Mer | ||
Ligand | BDBM50384598 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Inhibition Assay | ||
IC50 | 55±n/a nM | ||
Citation | Wang, X; Liu, J; Yang, C; Zhang, W; Frye, S; Kireev, D Pyrazolopyrimidine compounds for the treatment of cancer US Patent US9744172 Publication Date 8/29/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase Mer | |||
Name: | Tyrosine-protein kinase Mer | ||
Synonyms: | MER | MER intracellular domain/EGFR extracellular domain chimera | MERTK | MERTK_HUMAN | Proto-oncogene c-Mer | Proto-oncogene tyrosine-protein kinase MER | Receptor tyrosine kinase MerTK | Tyrosine-protein kinase Mer | ||
Type: | PROTEIN | ||
Mol. Mass.: | 110234.77 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_1498723 | ||
Residue: | 999 | ||
Sequence: |
| ||
BDBM50384598 | |||
n/a | |||
Name | BDBM50384598 | ||
Synonyms: | CHEMBL2036788 | US9744172, Compound UNC00000393A | ||
Type | Small organic molecule | ||
Emp. Form. | C25H28N6 | ||
Mol. Mass. | 412.53 | ||
SMILES | CNc1ncc2c(nn(CC3CCC(N)CC3)c2n1)-c1ccc(cc1)-c1ccccc1 |(2.22,-28.77,;3.55,-29.54,;4.89,-28.77,;4.89,-27.22,;6.22,-26.45,;7.55,-27.22,;9.03,-26.74,;9.94,-27.99,;9.03,-29.25,;9.5,-30.71,;8.47,-31.86,;6.96,-31.52,;5.94,-32.66,;6.41,-34.13,;5.37,-35.27,;7.91,-34.45,;8.95,-33.31,;7.55,-28.77,;6.22,-29.54,;9.5,-25.27,;11.01,-24.96,;11.49,-23.49,;10.45,-22.35,;8.94,-22.68,;8.47,-24.14,;10.92,-20.89,;12.43,-20.57,;12.91,-19.11,;11.87,-17.96,;10.36,-18.29,;9.89,-19.75,)| | ||
Structure |